Wednesday, November 11, 2026
ExploreSearch
Via News
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Press releaseGlobeNewswire· February 11, 2026

OP Mortgage Bank: Financial Statements Bulletin for 1 January‒31 December 2025

View original at globenewswire.com
OP Mortgage Bank: Financial Statements Bulletin for 1 January‒31 December 2025 OP Mortgage Bank Financial Statements Bulletin Stock Exchange Release 11 February 2026 at 10.00 EET OP Mortgage Bank: Financial Statements Bulletin for 1 January‒31 December 2025 OP Mortgage Bank is the covered bond issuing entity of OP Pohj…
Opening lines of the source · GlobeNewswire · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Overcollateralisation exceeded the minimum requirement under the Act (688/2010) for EMTCN programme

    80% confidence

  • OP Mortgage Bank clearly exceeds the MREL requirement

    80% confidence

  • OP Mortgage Bank's financial standing remained stable throughout the reporting period

    80% confidence

  • The key credit risk indicators in use show that OP Mortgage Bank's credit risk exposure is stable

    80% confidence

  • OP Pohjola aims to grow its nature positive impact by 2030

    80% confidence

  • Overcollateralisation exceeded the minimum requirement under the Act (151/2022) for EMTCB programme

    80% confidence

  • The Finnish economy is expected to recover gradually

    80% confidence

  • OP Mortgage Bank's interest risk exposure is under control and has been within the set limit

    80% confidence

  • OP Mortgage Bank's capital adequacy is expected to remain strong and its risk exposure favourable. This enables issuance of new covered bonds.

    80% confidence

  • 'Nature positive' means that OP Pohjola's operations will have a net positive impact (NPI) on nature

    80% confidence

Cited in these Via News reports

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Biotech Catalyst Wave: Late-2026 Clinical Readouts, PDUFA Dates and Capital Restructuring
A dense cluster of Q4 2026 to Q1 2027 clinical and regulatory catalysts spans hepatitis delta (Vir's ECLIPSE/SOLSTICE), hypertension and sleep apnea (Mineralys' lorundrostat, PDUFA 2026-12-22), severe hypertriglyceridemia (plozasiran), oncology (ivonescimab BLA, PDUFA 2026-11-14) and gene therapy (Krystal). Positive data flow from AASLD and AHA presentations is offset by cost-cutting guidance, milestones slipping into 2027, and a delisting process that signals capital-market stress for some issuers. Near-term value hinges on binary FDA decisions and Phase 3 topline readouts in Q1 2027.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,564 source documents archived
Query this data → isubstrate.com
OP Mortgage Bank: Financial Statements Bulletin for 1 January‒31 December 2025 — Source | Via News | Via News